Lv4
580 积分 2024-04-28 加入
Rationale for CD40 pathway blockade in autoimmune rheumatic disorders
13小时前
已完结
Retinal Toxicity, in vivo and in vitro, Associated with Inhibition of Nicotinamide Phosphoribosyltransferase
2个月前
已完结
Preclinical models of nicotinamide phosphoribosyltransferase inhibitor-mediated hematotoxicity and mitigation by co-treatment with nicotinic acid
2个月前
已完结
Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomas
9个月前
已完结
A DXd/TLR7-Agonist Dual-Conjugate Anti-HER2 ADC Exerts Robust Antitumor Activity Through Tumor Cell Killing and Immune Activation
10个月前
已完结
Clinical Activity of CC-90009, a Cereblon E3 Ligase Modulator and First-in-Class GSPT1 Degrader, As a Single Agent in Patients with Relapsed or Refractory Acute Myeloid Leukemia (R/R AML): First Results from a Phase I Dose-Finding Study
10个月前
已完结
Clinical Activity of CC-90009, a Cereblon E3 Ligase Modulator and First-in-Class GSPT1 Degrader, As a Single Agent in Patients with Relapsed or Refractory Acute Myeloid Leukemia (R/R AML): First Results from a Phase I Dose-Finding Study
10个月前
已关闭
Clinical Activity of CC-90009, a Cereblon E3 Ligase Modulator and First-in-Class GSPT1 Degrader, As a Single Agent in Patients with Relapsed or Refractory Acute Myeloid Leukemia (R/R AML): First Results from a Phase I Dose-Finding Study
10个月前
已关闭
Biomarkers for Antibody–Drug Conjugates in Solid Tumors
1年前
已完结
New guise ADCs couple antibodies to degraders
1年前
已完结
皖公网安备34019202002308
